Detalles de la búsqueda
1.
Comprehensive Evaluation of Multiple Approaches Targeting ABCB1 to Resensitize Docetaxel-Resistant Prostate Cancer Cell Lines.
Int J Mol Sci
; 24(1)2022 Dec 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-36614114
2.
Acquired resistance to irradiation or docetaxel is not associated with cross-resistance to cisplatin in prostate cancer cell lines.
J Cancer Res Clin Oncol
; 148(6): 1313-1324, 2022 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-35020044
3.
Assessment of STAT5 as a potential therapy target in enzalutamide-resistant prostate cancer.
PLoS One
; 15(8): e0237248, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32790723
4.
Author Correction: Mast cells increase adult neural precursor proliferation and differentiation but this potential is not realized in vivo under physiological conditions.
Sci Rep
; 10(1): 19816, 2020 Nov 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-33168937
5.
PIAS1 is not suitable as a urothelial carcinoma biomarker protein and pharmacological target.
PLoS One
; 14(10): e0224085, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31639157
6.
Mast cells increase adult neural precursor proliferation and differentiation but this potential is not realized in vivo under physiological conditions.
Sci Rep
; 7(1): 17859, 2017 12 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-29259265
Resultados
1 -
6
de 6
1
Próxima >
>>